Subtypes and Mechanisms of Hypertrophic Cardiomyopathy Proposed by Machine Learning Algorithms

Mila Glavaški1, Andrej Preveden1,2, Đorđe Jakovljević3,4

  • 1Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.

Life (Basel, Switzerland)
|October 27, 2022
PubMed

Insights

This study used machine learning to identify four subtypes of hypertrophic cardiomyopathy (HCM) in adult patients. These findings offer new insights into the complex mechanisms underlying this inherited cardiac disease.

Area of Science:

  • Cardiology
  • Medical Informatics
  • Genetics

Background:

  • Hypertrophic cardiomyopathy (HCM) is a common inherited cardiac condition causing left ventricular hypertrophy.
  • Understanding HCM subtypes and mechanisms is crucial for effective patient management.

Purpose of the Study:

  • To identify distinct subtypes of nonobstructive hypertrophic cardiomyopathy using machine learning.
  • To explore the underlying mechanisms of HCM through algorithmic analysis of clinical and laboratory data.

Main Methods:

  • Machine learning algorithms, including clustering and classification, were applied to analyze data from 143 adult patients with nonobstructive HCM.
  • Clustering identified optimal HCM subtypes, while classification models predicted the presence of specific HCM features.

Main Results:

  • Four distinct clusters, representing potential HCM subtypes, were identified as optimal for the dataset.
  • Predictive models were developed to identify HCM features based on genotypic and phenotypic information, revealing key feature subsets.

Conclusions:

  • The study proposes four novel subtypes of hypertrophic cardiomyopathy based on machine learning analysis of phenotypic expression.
  • Identifying feature subsets offers deeper insights into HCM mechanisms and aids in subtype characterization.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
37
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
41
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
27
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31